Welcome to LookChem.com Sign In|Join Free
  • or
2,6-Piperidinedimethanol, 1-[(4-methylphenyl)sulfonyl]-, bis(4-methylbenzenesulfonate) (ester), (2R,6S)-rel- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

381223-76-3

Post Buying Request

381223-76-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

381223-76-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 381223-76-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,1,2,2 and 3 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 381223-76:
(8*3)+(7*8)+(6*1)+(5*2)+(4*2)+(3*3)+(2*7)+(1*6)=133
133 % 10 = 3
So 381223-76-3 is a valid CAS Registry Number.

381223-76-3Relevant academic research and scientific papers

Stereoselective and regioselective synthesis of azepane and azepine derivatives via piperidine ring expansion

Chong, Hyun-Soon,Ganguly, Bishwajit,Broker, Grant A.,Rogers, Robin D.,Brechbiel, Martin W.

, p. 2080 - 2086 (2002)

Diastereomerically pure azepane derivatives 5, 13 were prepared by piperidine ring expansion with exclusive stereoselectivity and regioselectivity and in excellent yield. The structure and stereochemistry of 5 were confirmed via X-ray crystallographic analysis. The ring expansion strategy was applied to the construction of an azepine backbone 22 of a potential biologically active compound. The regiochemistry and stereochemistry of the piperidine ring expansion process were investigated by semiempirical molecular orbital calculations.

Synthesis of DTPA analogues derived from piperidine and azepane: Potential contrast enhancement agents for magnetic resonance imaging

Chong,Garmestani,Bryant Jr.,Brechbiel

, p. 7745 - 7750 (2007/10/03)

Two DTPA derivatives (PIP-DTPA and AZEP-DTPA) as potential contrast enhancement agents in MRI are synthesized. The T1 and T2 relaxivities of their corresponding Gd(III) complexes are reported. At clinically relevant field strengths, the relaxivities of the complexes are comparable to that of the contrast agent, Gd(DTPA) which is in clinical use. The serum stability of the 153Gd-labeled complexes is assessed by measuring the release of 153Gd from the ligands. The radiolabeled Gd chelates are found to be kinetically stable in human serum for up to at least 14 days without any measurable loss of radioactivity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 381223-76-3